JP2015514809A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514809A5
JP2015514809A5 JP2015509147A JP2015509147A JP2015514809A5 JP 2015514809 A5 JP2015514809 A5 JP 2015514809A5 JP 2015509147 A JP2015509147 A JP 2015509147A JP 2015509147 A JP2015509147 A JP 2015509147A JP 2015514809 A5 JP2015514809 A5 JP 2015514809A5
Authority
JP
Japan
Prior art keywords
microspheres
composition
aspect ratio
mannitol
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509147A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514809A (ja
JP6577865B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/038257 external-priority patent/WO2013163453A1/en
Publication of JP2015514809A publication Critical patent/JP2015514809A/ja
Publication of JP2015514809A5 publication Critical patent/JP2015514809A5/ja
Application granted granted Critical
Publication of JP6577865B2 publication Critical patent/JP6577865B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2015509147A 2012-04-25 2013-04-25 結晶性マイクロスフェアおよびその同じ物を製造するためのプロセス Active JP6577865B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261638073P 2012-04-25 2012-04-25
US61/638,073 2012-04-25
US201361783603P 2013-03-14 2013-03-14
US61/783,603 2013-03-14
PCT/US2013/038257 WO2013163453A1 (en) 2012-04-25 2013-04-25 Crystalline microspheres and the process for manufacturing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019043904A Division JP2019112438A (ja) 2012-04-25 2019-03-11 結晶性マイクロスフェアおよびその同じ物を製造するためのプロセス

Publications (3)

Publication Number Publication Date
JP2015514809A JP2015514809A (ja) 2015-05-21
JP2015514809A5 true JP2015514809A5 (enExample) 2017-08-10
JP6577865B2 JP6577865B2 (ja) 2019-09-18

Family

ID=49483900

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015509147A Active JP6577865B2 (ja) 2012-04-25 2013-04-25 結晶性マイクロスフェアおよびその同じ物を製造するためのプロセス
JP2019043904A Pending JP2019112438A (ja) 2012-04-25 2019-03-11 結晶性マイクロスフェアおよびその同じ物を製造するためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019043904A Pending JP2019112438A (ja) 2012-04-25 2019-03-11 結晶性マイクロスフェアおよびその同じ物を製造するためのプロセス

Country Status (9)

Country Link
US (5) US9089487B2 (enExample)
EP (2) EP3583935A1 (enExample)
JP (2) JP6577865B2 (enExample)
BR (1) BR112014026351B1 (enExample)
CA (1) CA2871429C (enExample)
ES (1) ES2729035T3 (enExample)
IN (1) IN2014DN09416A (enExample)
MX (1) MX359554B (enExample)
WO (1) WO2013163453A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL219362A (en) 2012-04-23 2017-04-30 Verint Systems Ltd A system and method for predicting threatened points of interest
IN2014DN09416A (enExample) 2012-04-25 2015-07-17 Spi Pharma Inc
US10560842B2 (en) 2015-01-28 2020-02-11 Verint Systems Ltd. System and method for combined network-side and off-air monitoring of wireless networks
IL242354B (en) 2015-10-29 2019-09-26 Verint Systems Ltd System and method for identifying genuine base stations that serve rogue base stations
IL245299B (en) 2016-04-25 2021-05-31 Verint Systems Ltd A system and method for decoding communication transmitted in a wireless local communication network
CN113365609A (zh) 2019-01-31 2021-09-07 伊勒卓菲公司 颗粒形成和形态
WO2021050953A1 (en) 2019-09-13 2021-03-18 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
US10639312B1 (en) * 2019-12-06 2020-05-05 Edenbridge Pharmaceuticals, LLC Finished pharmaceutical dosage form of a methenamine salt such as methenamine mandelate

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
JPH0192403A (ja) 1987-09-30 1989-04-11 Aprica Kassai Inc 使い捨ておむつ
FR2670398B1 (fr) * 1990-12-14 1995-02-17 Roquette Freres Composition pulverulente directement compressible et procede d'obtention.
US5573783A (en) 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
US6548095B1 (en) 1996-08-24 2003-04-15 Südzucker Aktiengesellschaft Sugar-free compressed products
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US5780055A (en) 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
JPH1092403A (ja) 1996-09-17 1998-04-10 Sanyo Electric Co Ltd 電池収納機構及びこれを具えた電子機器
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2002035991A2 (en) * 2000-10-30 2002-05-10 The Board Of Regents, The University Of Texas System Spherical particles produced by a hot-melt extrusion/spheronization process
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
MXPA04009385A (es) * 2002-03-26 2005-01-25 Teva Pharma Microparticulas de drogas.
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
WO2004067595A2 (en) * 2003-01-29 2004-08-12 Spi Polyols, Inc. Compositions of polyol granules and processes of manufacture
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
US20070092562A1 (en) 2003-10-28 2007-04-26 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
WO2005044193A2 (en) * 2003-10-28 2005-05-19 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
CA2549225A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
EP1753404A1 (en) * 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
EP1817009A2 (en) 2004-11-24 2007-08-15 Spi Pharma, Inc. Orally disintegrating compositions
CN101155859B (zh) * 2005-04-06 2012-04-25 三洋化成工业株式会社 树脂颗粒和树脂分散体
JP2007217651A (ja) 2006-02-20 2007-08-30 Daicel Chem Ind Ltd 環状ポリオレフィン系樹脂の球状粒子およびその製造方法
PL2046269T3 (pl) * 2006-08-01 2011-05-31 Procter & Gamble Cząstka dostarczająca zawierająca korzystny środek
EP2091519B1 (en) 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008094877A2 (en) 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
CA2687794C (en) * 2007-05-28 2015-01-27 Jin Satomi Spherical particle of crystalline mannitol
JP5258268B2 (ja) 2007-11-19 2013-08-07 フロイント産業株式会社 球形粒の製造方法
US8895141B2 (en) * 2008-08-18 2014-11-25 Mitsubishi Shoji Foodtech Co., Ltd. Excipient for compressed tablets comprising novel spherical mannitol
MX2011009053A (es) 2009-03-09 2012-04-02 Spi Pharma Inc Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
PL2427177T3 (pl) * 2009-05-08 2018-09-28 Emplicure Ab Kompozycja do przedłużonego podawania leku zawierająca geopolimerowy środek wiążący
JP2011157348A (ja) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd 崩壊性高強度球状粒子組成物
DE102010045479A1 (de) 2010-09-16 2014-10-30 Brace Capital Gmbh Verfahren zur Mikroverkapselung, Herstellung von festen Formen mehrphasiger mischbarer und nichtmischbarer Materialien und Methode zur Herstellung vorgenannter Systeme
CN103619514B (zh) 2010-09-20 2016-09-28 Spi制药公司 微包囊方法和制品
IN2014DN09416A (enExample) * 2012-04-25 2015-07-17 Spi Pharma Inc

Similar Documents

Publication Publication Date Title
JP6620029B2 (ja) 球状粒子からなる金属粉末
TWI359113B (enExample)
JP6154507B2 (ja) 銀被覆銅合金粉末およびその製造方法
JP5865243B2 (ja) 金属コーティング材及び金属コーティング材の製造方法
Kondo et al. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate
US20220151932A1 (en) Crystalline microspheres and the process of manufacturing the same
TW200408475A (en) Copper flake powder, method for producing copper flake powder, and conductive paste using copper flake powder
JPWO2010098441A1 (ja) 造形用粉末及びこれを用いる造形物の製造方法
JP2017071558A (ja) 錠剤の衝撃耐性改善賦形剤
CN104046821B (zh) 一种表征WC-Co硬质合金混合料烧结活性的方法
TWI683004B (zh) 球狀Ti系粉末及其製造方法
Rahangdale et al. In vitro Evaluation of Floating Microspheres of Gabapentin by Solvent Evaporation Method
JP2020125526A (ja) 炭素繊維三次元構造体及びその製造方法
JP2019003988A (ja) 磁性体膜及びその製造方法
WO2019208463A1 (ja) C含有スパッタリングターゲット及びその製造方法
TW201631213A (zh) 用於生產含有顆粒的氣溶膠之方法
JP2024525494A (ja) ポリマー複合物、およびその調製方法と使用
Loca et al. Evaluation of Highly-Water Soluble Drug Physical State in Biodegradable Microcapsules
Zellnitz et al. Enhancing the performance of dry powder inhalers by tailoring interparticle forces via surface modification of carrier and active